The trademark application was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on September 12, 2022, and it was registered by office on December 20, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).